Key facts
- This page summarizes John A. Engerman's Form 4 filing for Altisource Asset Management Corp.
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 Dec 2022, 12:51.
John A. Engerman - 14 Dec 2022 Form 4 Insider Report for Altisource Asset Management Corp
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 14 Dec 2022
- Net transaction value
- +$50,652
- SEC form
- 4
- Accepted by SEC
- 16 Dec 2022, 12:51:54 UTC
- Prior SEC filing
- 09 Nov 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kevin Sullivan, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
John A. Engerman filed Form 4 for Altisource Asset Management Corp on 16 Dec 2022.
Change
- Previous filing in this sequence was filed on 09 Nov 2021.
- Current net transaction value: +$50,652.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AAMC
transaction
Common stock
Award
- Transaction value
- $50,652
- Shares
- +2,412
- Change %
- +34%
- Price
- $21.00
- Shares after
- 9,517
- Date
- 14 Dec 2022
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AAMC
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +2,857
- Change %
- Price
- $0.000000
- Shares after
- 2,857
- Date
- 14 Dec 2022
- Ownership
- Direct
- Underlying class
- common stock
- Underlying amount
- 2,857
- Exercise price
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Director Stock Grant issued pursuant to the AAMC 2020 Equity Incentive Plan.
Footnote F2
Shares of common stock underlying these Restricted Stock Units will be delivered on or after the date of the 2023 Annual Meeting of Stockholders.